retatrutide clinical trials phase III study demonstrates 30% weight loss Retatrutide Phase 3: TRIUMPH Program

INSL5 is a novel marker for human enteroendocrine cells of the large intestine and neuroendocrine tumours

Peptides that are impure or contaminated can compromise the integrity of experiments, leading to inconsistent results

[13] On 2 May 2023, Jenny Craig announced to employees via email that the company will wind down operations, lay off all employees, and possibly switch to an e-commerce model

The pill format will likely increase the adoption of GLP-1 medications due to its lower pricing and convenience, with Novo Nordisks Wegovy pill being priced between $149 to $299 per month versus an average price of $1,000 per month for GLP-1 injectables, for example